Intellectual Property

  • December 13, 2024

    UK Litigation Roundup: Here's What You Missed In London

    This past week in London has seen a group of franchise operators hit Vodafone with a £120 million ($151 million) claim for allegedly imposing commission cuts, green energy tycoon Dale Vince pursue another libel action against the publisher of the Daily Mail, and parcel delivery giant Yodel face a claim by an investor that helped save it from collapse earlier in the year.

  • December 13, 2024

    Judge Finds Wireless Patent Claim Indefinite In Samsung Feud

    A Delaware federal magistrate judge has sided with Samsung on how to interpret a key claim in a wireless communications patent it was accused of infringing, finding the term was indefinite.

  • December 13, 2024

    Tesla Gets PTAB To Cut Some Claims In 2 AI Vehicle Patents

    The Patent Trial and Appeal Board has found that most of the challenged claims across two patents related to the use of artificial intelligence in self-driving vehicles are invalid, handing a win to challenger Tesla.

  • December 13, 2024

    ITC To Review Design Patent Case Over Blue-Soled Shoes

    The U.S. International Trade Commission has agreed to investigate whether a New York-based company and a group of overseas entities are importing women's flats that infringe design patents belonging to the maker of Tieks shoes.

  • December 13, 2024

    ByteDance Ex-Coder Perjured Himself In Suit, Judge Finds

    A California federal judge imposed terminating sanctions against a former engineer at TikTok's parent company, finding he committed perjury in a suit alleging he was wrongly fired and ordered the dispute to arbitration.

  • December 13, 2024

    'Copycat' Nantucket Wine Event Ordered To Issue Retraction

    A Massachusetts liquor distributor was ordered Friday by a federal judge to post a bold-type correction and issue press releases retracting claims that it had acquired and "re-branded" a long-running Nantucket wine and food festival.

  • December 13, 2024

    What's Left In $400M Skinny Label Row? A Lot, Court Says

    A number of key issues remain live in the $400 million fight between Teva Pharmaceuticals and GlaxoSmithKline over whether the generic-drug maker induced healthcare providers to infringe the brand-name company's heart drug patent, including the availability of a new trial, a Delaware federal judge has said.

  • December 13, 2024

    Ex-Judges, Atty Group Back Newman In Suspension Lawsuit

    U.S. Circuit Judge Pauline Newman has received more support at the D.C. Circuit in her case over the suspension her colleagues imposed on her for refusing to participate in an investigation into her fitness to serve as a Federal Circuit judge, this time from a group of former federal judges and the Bar Association of the District of Columbia.

  • December 13, 2024

    Off The Bench: PE Buys In On NFL, WWE Abuse Suit Back On

    In this week's Off The Bench, two teams usher in a new era for the NFL by bringing in private equity investors, a suit accusing the WWE and Vince McMahon of sexual abuse and trafficking picks back up while a federal investigation continues, and a private equity giant and NHL owner passes away.

  • December 12, 2024

    Moderna Fires Back With Counterclaims In GSK RSV Vax Suit

    Moderna Inc. on Thursday lodged counterclaims in Delaware federal court accusing GlaxoSmithKline of failing to develop its own vaccine for respiratory syncytial virus, and then "resorting to the courtroom" and GSK's "manipulation of the United States patent system" to go after Moderna.

  • December 12, 2024

    WGA Urges Major Studios To Take Legal Action Over AI 'Theft'

    The Writers Guild of America on Wednesday called on several major entertainment studios to swiftly take legal action against technology companies they assert are stealing writers' works to train artificial intelligence systems and making billions of dollars from the "wholesale theft."

  • December 12, 2024

    Vidal Reflects On USPTO Achievements As She Leaves Office

    Kathi Vidal will serve her last day as U.S. Patent and Trademark Office director on Friday and rejoin her former firm, Winston & Strawn LLP, on Monday. She talked to Law360 as she prepared her exit from the agency, with internal changes top of mind as she looked back on her tenure.

  • December 12, 2024

    Align Tech's $27.5M Antitrust Deal Hits Nerve With Judge

    A California federal judge said Thursday that a proposed $27.5 million deal for teeth-aligner buyers to resolve antitrust claims alleging Align Technologies Inc. colluded with the now-bankrupt SmileDirectClub to illegally restrict competition might be "inherently improper" due to a coupon component that "would bring additional business to the monopolist."

  • December 12, 2024

    Carlisle Cleared In Patent Trial Over Spray Guns

    Jurors cleared Carlisle's construction materials company on Thursday from allegations in Delaware federal court that the Pennsylvania company was infringing a single claim in a rival's patent that covered a spray gun marketed to construction workers.

  • December 12, 2024

    T-Mobile Says Split On TM Use Must Be Resolved By Justices

    T-Mobile is asking the U.S. Supreme Court to review a Fourth Circuit panel's revival of a prepaid cellphone company's trademark infringement suit, telling the justices in a new petition this week that trademarks should have to be in continuous use for their holders to be able to protect them.

  • December 12, 2024

    Coke Zero Sweetener Co. Asks Justices To Hear Patent Feud

    The company that developed the artificial sweetener used in Coke Zero wants to keep patents that were filed at the patent office after the drinks went on sale, telling the U.S. Supreme Court that Federal Circuit judges who thought otherwise were prioritizing their "own decisions over Congress's judgment."

  • December 12, 2024

    Calif. Judge Kills Software Patent Suit Under Alice

    A California federal judge on Thursday threw out a patent infringement lawsuit by a bankrupt startup against one of Salesforce's brands, saying the claims in the patents didn't pass muster under the test laid out in the U.S. Supreme Court's Alice decision.

  • December 12, 2024

    Medicare Could Lose Billions From 'Patent Abuse,' Group Says

    The $6 billion a year Medicare is supposed to save by negotiating drug prices under the Inflation Reduction Act is close to the billions of dollars the government could lose due to "patent abuse" by drugmakers, according to a new report by a consumer interest group.

  • December 12, 2024

    Photobucket Accused Of Training AI On Photos Sans Consent

    A proposed class action filed in Colorado federal court Wednesday alleges that image hosting website Photobucket unlawfully used billions of photographs uploaded by users for biometric data and training artificial intelligence.

  • December 12, 2024

    Nvidia Should Go First In Patent Suit, Microsoft Tells Albright

    Microsoft says Nvidia should be the first to face patent infringement claims from a Texas startup that initiated a legal fight targeting microchips used to power Microsoft's generative artificial intelligence models, saying the chipmaker is the "only source" of the products at issue in the lawsuit.

  • December 12, 2024

    Newman Gets Amicus Support At DC Circ. In Suspension Row

    Two amici threw their support behind U.S. Circuit Judge Pauline Newman at the D.C. Circuit on Thursday, with one free-market think tank criticizing what it said was the secrecy surrounding the disciplinary proceedings against Judge Newman over her refusal to participate in an investigation into her fitness to serve as a Federal Circuit judge.

  • December 12, 2024

    Ex-Mich. Football Stars Eye 'Early' Class Cert. In $50M NIL Suit

    Former University of Michigan football players seeking more than $50 million from the NCAA and Big Ten Network asked a judge to certify their proposed student-athlete class on Thursday, while noting it was "admittedly early" in the case to do so.

  • December 12, 2024

    Sam Adams Maker Using 'Draconian' Noncompete, Court Told

    A former Boston Beer Co. sales worker told a Massachusetts federal judge on Thursday that the Sam Adams brewer is aggressively enforcing noncompete agreements that don't comply with state law.

  • December 12, 2024

    Luchador Law's Bid For Round 1 TM Win May Be Doomed

    A California federal judge appeared ready Thursday to body-slam personal injury firm Luchador Law's bid to quickly toss a trademark lawsuit by a rival firm that owns the trademark for 1-800-LUCHADOR, saying he thinks the word's meaning is in dispute and issuing a tentative ruling denying the motion.

  • December 12, 2024

    Albright Confirms Move To Austin, Pending 5th Circ. Sign-Off

    U.S. District Judge Alan Albright is in the process of moving from the Western District of Texas' Waco division to Austin, and he's just awaiting a vote from the Fifth Circuit Judicial Council, he confirmed Thursday.

Expert Analysis

  • How 2 Proposed Bills Could Transform Patent Law

    Author Photo

    The Patent Eligibility Restoration Act and the Prevail Act may come up for vote by the Senate Judiciary Committee after the election, and both offer benefits and challenges for inventors and companies seeking to obtain patents, says Philip Nelson at Knobbe Martens.

  • 7 Tips To Help Your Witness Be A Cross-Exam Heavyweight

    Author Photo

    Because jurors tend to pay a little more attention to cross-examination, attorneys should train their witnesses to strike a balance — making it tough for opposing counsel to make their side’s case, without coming across as difficult to the jury, says Ken Broda-Bahm at Persuasion Strategies.

  • Series

    Beekeeping Makes Me A Better Lawyer

    Author Photo

    The practice of patent law and beekeeping are not typically associated, but taking care of honeybees has enriched my legal practice by highlighting the importance of hands-on experience, continuous learning, mentorship and more, says David Longo at Oblon McClelland.

  • Budding Lessons From Landmark Plant Seed Patent Battle

    Author Photo

    The Corteva v. Inari case involving intellectual property rights in genetically modified plants is now proceeding through discovery and potentially to trial, and will raise critical questions that could have a major impact on the agriculture technology industry, say Tate Tischner and Andrew Zappia at Troutman Pepper.

  • The Key To Solving High Drug Costs Is Understanding Causes

    Author Photo

    One-sided views on who or what contributes to the high cost of pharmaceuticals render possible solutions much harder to discover and implement, and a better approach would be to examine history and learn why costs have increased and what legislation has and hasn't helped, says Nancy Linck at NJ Linck Consulting.

  • Challenges Of Insuring An NIL Collective

    Author Photo

    Sarah Abrams at Baleen Specialty examines the emergence of name, image and likeness collectives for student-athletes, the current litigation landscape that has created a favorable environment for these organizations, and considerations for director and officer insurers looking to underwrite NIL collectives.

  • Opinion

    Legal Institutions Must Warn Against Phony Election Suits

    Author Photo

    With two weeks until the election, bar associations and courts have an urgent responsibility to warn lawyers about the consequences of filing unsubstantiated lawsuits claiming election fraud, says Elise Bean at the Carl Levin Center for Oversight and Democracy.

  • Opinion

    Bring Back Patent Models To Shut Down The Patent Trolls

    Author Photo

    By reintroducing the requirement that inventors submit a miniature working model of their inventions along with their patent, legislators could help to deter patent trolls, reduce frivolous litigation and support legitimate inventors in protecting their innovations, says Darin Gibby at Kilpatrick.

  • Strategies To Avoid Patent Issues In AI Drug Discovery

    Author Photo

    Artificial intelligence has the potential to improve drug discovery and design, but companies should consider a variety of factors when patenting drugs created using AI systems, including guidance from the U.S. Patent and Trademark Office and methods for protecting patent eligibility, say attorneys at Ropes & Gray.

  • How Cos. Can Build A Strong In-House Pro Bono Program

    Author Photo

    During this year’s pro bono celebration week, companies should consider some key pointers to grow and maintain a vibrant in-house program for attorneys to provide free legal services for the public good, says Mary Benton at Alston & Bird.

  • Insights On NLRB General Counsel's New 'Stay-Or-Pay' Memo

    Author Photo

    Attorneys at Davis Wright discuss the National Labor Relations Board general counsel's new memorandum on employer “stay-or-pay” policies and noncompete agreements, and explain key takeaways concerning the proposed financial remedies, prosecution framework and more.

  • Series

    Home Canning Makes Me A Better Lawyer

    Author Photo

    Making my own pickles and jams requires seeing a process through from start to finish, as does representing clients from the start of a dispute at the Patent Trial and Appeal Board through any appeals to the Federal Circuit, says attorney Kevin McNish.

  • 5 Considerations For Obviousness-Type Double Patenting

    Author Photo

    The U.S. Supreme Court’s recent denial of certiorari for In re: Cellect highlights the current state of obviousness-type double patenting based on that case and another recent Federal Circuit decision, including that ODP is not fatal, that divisional applications are protected from ODP and more, says Fabian Koenigbauer at Ice Miller.

  • Patent Lessons From 7 Federal Circuit Reversals In August

    Author Photo

    The Federal Circuit’s seven vacated or reversed cases from August provide helpful clarity on obviousness-type double patenting, written description and indefiniteness, and suggest improved practices for petitioners and patent owners in inter partes review, say Denise De Mory and Li Guo at Bunsow De Mory.

  • Use The Right Kind Of Feedback To Help Gen Z Attorneys

    Author Photo

    Generation Z associates bring unique perspectives and expectations to the workplace, so it’s imperative that supervising attorneys adapt their feedback approach in order to help young lawyers learn and grow — which is good for law firms, too, says Rachael Bosch at Fringe Professional Development.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!